Novel Anti-fibrotic Therapies

por McVicker, Benita L., Bennett, Robert G.
Publicado 2017

Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis

por Bennett, Robert G, Simpson, Ronda L, Hamel, Frederick G
Publicado 2017

Redox Regulation of Insulin Degradation by Insulin-Degrading Enzyme

por Cordes, Crystal M., Bennett, Robert G., Siford, Gerri L., Hamel, Frederick G.
Publicado 2011

Reduction in Obesity-Related Hepatic Fibrosis by SR1664

por McVicker, Benita L., Simpson, Ronda L., Hamel, Frederick G., Bennett, Robert G.
Publicado 2023

A Selective PPARγ Modulator Reduces Hepatic Fibrosis

por McVicker, Benita L., Hamel, Frederick G., Simpson, Ronda L., Bennett, Robert G.
Publicado 2020

Alcohol-induced tubulin post-translational modifications directly alter hepatic protein trafficking

por Adhikari, Raghabendra, Mitra, Ramyajit, Bennett, Robert G., McVicker, Benita L., Tuma, Pamela L.
Publicado 2023

SAT524 Relaxin: A Novel Marker for Pro-Tumoral Thyroid Cancer Microenvironment?

por Kotwal, Anupam, Bennett, Robert G, Swanson, Benjamin, Goldner, Whitney, Yuil-Valdes, Ana, Whiteman, Nicholas, Shats, Oleg
Publicado 2023

Insulin Degrading Enzyme Induces a Conformational Change in Varicella-Zoster Virus gE, and Enhances Virus Infectivity and Stability

por Li, Qingxue, Ali, Mir A., Wang, Kening, Sayre, Dean, Hamel, Frederick G., Fischer, Elizabeth R., Bennett, Robert G., Cohen, Jeffrey I.
Publicado 2010

Dually Active Polycation/miRNA Nanoparticles for the Treatment of Fibrosis in Alcohol-Associated Liver Disease

por Zhang, Chuhan, Hang, Yu, Tang, Weimin, Sil, Diptesh, Jensen-Smith, Heather C., Bennett, Robert G., McVicker, Benita L., Oupický, David
Publicado 2022